Effect of adalimumab on clinical laboratory parameters in patients with Crohns disease: Results from the CHARM trial
Inflammatory Bowel Disease,  Clinical Article

Rubin DT et al. – Adalimumab therapy for moderately to severely active Crohn's disease (CD) was associated with significant improvements in nutritional, hematologic, and inflammatory markers.

Methods
  • The authors evaluated the effect of adalimumab on changes in laboratory values using data from CHARM, in which patients were randomized to adalimumab 40 mg every other week (eow), adalimumab 40 mg weekly, or placebo for 56 weeks.
  • Mean changes in laboratory values from baseline to Weeks 26 and 56 were compared between adalimumab and placebo using analysis of covariance models.
  • Percentages of patients with suboptimal laboratory values at Weeks 26 and 56 were compared between treatment groups using Cochran-Mantel-Haenszel (CMH) tests.
  • Pearson correlation coefficients for associations between changes in Crohn's Disease Activity Index (CDAI) score and changes in laboratory values were estimated at Weeks 4, 26, and 56.

Results
  • The intention-to-treat analysis included 778 patients randomized to adalimumab eow (N=260), adalimumab weekly (N=257), or placebo (N=261).
  • Baseline abnormalities in laboratory values were common across treatment groups.
  • CMH tests revealed significantly lesser rates of suboptimal laboratory values with adalimumab vs. placebo at Week 26, including hypoalbuminemia, calcium deficiency, low hemoglobin, low hematocrit, low red blood cell count, elevated platelet count, and elevated C-reactive protein concentration (all P<0.05).
  • These improvements persisted at Week 56.
  • Improvements in CDAI from baseline to Weeks 4, 26, and 56 were significantly correlated with changes from baseline for albumin, hemoglobin, and C-reactive protein (all P<0.001).
Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

<

Most Popular Gastroenterology Articles

1 Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms Neurogastroenterology & Motility, February 25, 2014    Clinical Article
Exclusive Author Commentary

2 Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis Journal of Digestive Diseases, December 4, 2014    Evidence Based Medicine    Review Article

3 Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double-blind placebo-controlled trial Neurogastroenterology & Motility, February 10, 2014    Clinical Article

4 Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia Digestive Diseases and Sciences, December 12, 2014    Clinical Article

5 Variation in treatment of patients with inflammatory bowel diseases at major US referral centers Clinical Gastroenterology and Hepatology , December 1, 2014    Clinical Article

6 Vedolizumab: a review of its use in adult patients with moderately to severely active ulcerative colitis or Crohn’s disease BioDrugs, December 11, 2014    Review Article

7 Diet and inflammatory bowel disease: review of patient-targeted recommendations Clinical Gastroenterology and Hepatology , October 10, 2014    Review Article

8 Accuracy of rapid fecal calprotectin test in monitoring inflammatory bowel diseases under treatment with TNFα antagonists Digestive Diseases and Sciences, December 9, 2014    Clinical Article

9 Long-term outcome of patients with Crohn’s disease who discontinued infliximab therapy upon clinical remission Clinical Gastroenterology and Hepatology , December 5, 2014    Clinical Article

10 The results of seton drainage combined with anti-TNF therapy for anal fistula in Crohn's disease Colorectal Disease, December 3, 2014    Clinical Article

11 Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: A meta-analysis of controlled trials Digestive and Liver Diseases, December 8, 2014    Clinical Article

12 The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence following surgery for Crohn's disease Clinical Gastroenterology and Hepatology , November 7, 2014    Clinical Article

13 Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease Full Text Clinical and Experimental Gastroenterology, December 15, 2014    Free full text    Review Article

14 The home environment and childhood obesity in low-income households: indirect effects via sleep duration and screen time Full Text BMC Public Health, November 26, 2014    Free full text    Clinical Article

15 Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterology & Motility, December 3, 2014    Review Article

16 Why, when and how to de-escalate therapy in inflammatory bowel diseases Alimentary Pharmacology and Therapeutics, July 2, 2014    Review Article

17 Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the help randomized clinical trial JAMA Internal Medicine, October 13, 2014    Evidence Based Medicine    Clinical Article

18 Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease Gastroenterology, April 2, 2014    Clinical Article

19 Effectiveness of adalimumab in perianal fistulas in Crohn’s disease patients naive to anti-TNF therapy Journal of Clinical Gastroenterology, December 10, 2014    Clinical Article

20 Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity International Journal of Obesity, November 14, 2014    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List